Integrating Expression Data-Based Deep Neural Network Models with Biological Networks to Identify Regulatory Modules for Lung Adenocarcinoma
Source check: Source checked. Not independent scientific confirmation.
Finding: Deep neural-network analysis of lung adenocarcinoma expression data integrated with biological networks to nominate three candidate regulatory modules involving miR-30a, miR-182 and miR-145. These are computational candidate signatures rather than experimentally established regulatory mechanisms.
Technology: Deep neural networks with SHAP feature attribution screened RNA features that were integrated with biological networks to select regulatory modules in lung adenocarcinoma.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Deep neural networks with SHAP feature attribution screened RNA features that were integrated with biological networks to select regulatory modules in lung adenocarcinoma.
- Test and result
- The study applied neural-network modeling, SHAP feature attribution and network integration to expression data to identify three candidate modules.
- Limitation / still unknown
- The proposed modules are computational hypotheses and are not established causal mechanisms or clinical biomarkers.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2079-7737/11/9/1291
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text, including Methods and Results; first result-bearing version checked against primary publication metadata..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.